Drugs / rosiglitazone/metformin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00241605 | Jun 2003 → Dec 2005 | type 2 diabetes mellitus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rosiglitazone/metformin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00241605 ↗ |